Updated Jul 16, 2026
Yoshiyama Annie has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $29K.
Annie Yoshiyama is a corporate finance executive currently serving as the Senior Vice President of Finance at Allogene Therapeutics, Inc. She has experience in financial management and strategy within the biotechnology sector.
| Role | SVP, Finance |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-23 | ALLO | Allogene Therapeutics, Inc. | S — Open-market sale | 9.6K | $2.31 | $22K |
| 2026-02-04 | ALLO | Allogene Therapeutics, Inc. | S — Open-market sale | 4.2K | $1.72 | $7K |
Annie Yoshiyama is a corporate finance executive currently serving as the Senior Vice President of Finance at Allogene Therapeutics, Inc. She has experience in financial management and strategy within the biotechnology sector.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($29K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Yoshiyama Annie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.